🇺🇸 Heavy Bupivacaine in United States
6 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 6
Most-reported reactions
- Apgar Score Low — 1 report (16.67%)
- Arrhythmia — 1 report (16.67%)
- Cardiogenic Shock — 1 report (16.67%)
- Left Ventricular Dysfunction — 1 report (16.67%)
- Myocardial Infarction — 1 report (16.67%)
- Premature Baby — 1 report (16.67%)
Other Anesthesia approved in United States
Frequently asked questions
Is Heavy Bupivacaine approved in United States?
Heavy Bupivacaine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Heavy Bupivacaine in United States?
Diskapi Yildirim Beyazit Education and Research Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.